Table 4 |
|||
|
Sensitivity and specificity of Anti-Scl-70 in diagnosis of SSc |
|||
|
SSc versus: |
Assay used |
Sensitivity (%) |
Specificity (%) |
|
|
|||
|
Normal controls |
ID |
20* |
100* |
|
IB |
41* |
99.4* |
|
|
ELISA |
43* |
100* |
|
|
Overall |
34† |
99.6† |
|
|
Other connective tissue diseases |
ID |
26* |
99.5* |
|
IB |
40* |
99* |
|
|
ELISA |
43* |
90* |
|
|
Overall |
97.9† |
||
|
Primary Raynaud's phenomenon |
ID |
28* |
98* |
|
Non-SSc relatives |
ID |
25.5* |
100* † |
|
|
|||
|
*Reference [35]. †Reference [36]. ELISA, enzyme-linked immunosorbent assay; IB, immunoblotting; ID, immunodiffusion. |
|||
|
Ho and Reveille Arthritis Res Ther 2003 5:80 doi:10.1186/ar628 |
|||